ACPU
AVNR

Arrowgrass Capital Partners (US)’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-971,020
Closed -$16.5M – 596
2014
Q4 		$16.5M Buy
971,020
+844,282
+666% +$11.9M 0.29% 51
2014
Q3 		$1.51M Buy
+126,738
New +$865K 0.04% 204

Arrowgrass Capital Partners (US)'s AVNR Position: Q1 2015 in Review

Arrowgrass Capital Partners (US) sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 971,020 shares — an estimated $16.5M sold.

Arrowgrass Capital Partners (US) first reported a position in AVNR in Q3 2014 and held it in 2 quarters. The position peaked at $16.5M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Arrowgrass Capital Partners (US) reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 971,020 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $16.5M.
  • Arrowgrass Capital Partners (US) first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 2 quarters.
  • Arrowgrass Capital Partners (US)'s AVANIR PHARMACEUTICALS, INC CL A position peaked at $16.5M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2015, filed 15 May 2015.